Thomas Heineman

Director Técnico/Científico/I+D en ONCOLYTICS BIOTECH INC. .

Fortuna: 552 334 $ al 31/05/2024

Health Technology

Consumer Services

Cargos activos de Thomas Heineman

Empresas	Cargo	Inicio	Fin
ONCOLYTICS BIOTECH INC.	Director Técnico/Científico/I+D	01/08/2020	-

Empresas	Cargo	Inicio	Fin
Denovo Biopharma LLC Denovo Biopharma LLC Pharmaceuticals: MajorHealth Technology Denovo Biopharma LLC provides a novel biomarker solution to personalize drug development. It applies in oncology, metabolic, cardiology, immunology and neurology therapeutic areas. The company is headquartered in San Diego, CA.	Corporate Officer/Principal	01/01/2020	01/07/2020
GENOCEA BIOSCIENCES, INC.	Corporate Officer/Principal	01/08/2016	01/01/2020
HALOZYME THERAPEUTICS, INC.	Director Técnico/Científico/I+D	01/02/2018	01/01/2020
HALOZYME THERAPEUTICS, INC.	Corporate Officer/Principal	01/02/2018	01/01/2020
GSK PLC	Director Técnico/Científico/I+D	01/01/2006	01/08/2016
Saint Louis University School of Medicine	Corporate Officer/Principal	-	-

The University of Chicago

Doctorate Degree

Internacional

Operativa

Corporate Officer/Principal	4
Chief Tech/Sci/R&D Officer	3
Doctorate Degree	1

Sectorial

Health Technology	6
Consumer Services	3

Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Empresas privadas	1
Denovo Biopharma LLC Denovo Biopharma LLC Pharmaceuticals: MajorHealth Technology Denovo Biopharma LLC provides a novel biomarker solution to personalize drug development. It applies in oncology, metabolic, cardiology, immunology and neurology therapeutic areas. The company is headquartered in San Diego, CA.	Health Technology